Ajanta Pharma Ltd (AJANTPHARM) — Insider Trading | 27 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Promoters released pledges on RBL Bank loans and created new pledges with 360 One Prime Ltd.
🔄 What Changed
Release of pledges reducing encumbrance from 10.05% to 10.79% and creation of new 0.74% pledge with 360 One Prime Ltd.
💡 Investor Takeaway
Promoter shareholding remains stable at 14.47% each despite pledge adjustments, indicating no dilution or control change.

Ajanta Pharma Ltd disclosed that promoter group entities including Yogesh Agrawal Trust, Rajesh Agrawal Trust, and Ravi Agrawal Trust released pledges on 19-Aug-26 against RBL Bank loans, reducing encumbered shares from 10.05% to 10.79% of total capital. Concurrently, Ganga Exports created a new pledge on 21-Aug-26 for 0.74% of shares as additional security. The filing confirms promoter holdings remain unchanged at 14.47% each across three trusts, with no new encumbrances affecting overall promoter stake. [amount not verified] and [amount not verified] were repaid on the repayment date, while ₹30,000 shares were pledged with 360 One Prime Ltd.

📄 View Original Announcement (PDF)

About Ajanta Pharma Ltd (AJANTPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹44,226.59 Cr P/E: 39.0 ROE: 25.1% ROCE: 31.8% Div Yield: 0.79%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AJANTPHARM — Free

Free account · 2 AI queries/day